Market data and research context for informational purposes. Not investment advice.
Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in DKK.
Genmab A/S, a biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.
Also listed as GMAB (NasdaqGS)